Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 20, 2003. The report is a disclosure of changes in director interests in the company's Ordinary Shares, specifically relating to the GlaxoSmithKline US Retirement Savings Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on shareholding changes within a retirement fund.
Material Changes
- Retirement Fund Holdings: The number of Ordinary Share ADRs held by the GlaxoSmithKline US Retirement Savings Plan decreased from 18,818,366 to 18,778,359.
- Transaction Date: The movement occurred on October 17, 2003.
- Average Price: The shares were transacted at an average price of $43.30.
- Director Interest: Dr. J P Garnier is noted as potentially interested in the shares held in the fund, consistent with other employees and former employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The report is a routine disclosure of director interests.
Investor Verification Points
- Verify the impact of the ADR decrease on the total outstanding share count.
- Confirm the specific nature of Dr. J P Garnier's interest in the discretionary fund.
- Review the full Form 20-F for comprehensive financial performance data not included in this 6-K.